Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 02 08 2022
accepted: 26 10 2022
revised: 21 10 2022
pubmed: 17 11 2022
medline: 12 1 2023
entrez: 16 11 2022
Statut: ppublish

Résumé

School closures were enforced as measures to restrain the COVID-19 pandemic, based on the assumption that young children may play a key role in SARS-CoV-2 spread. This study aims to determine the prevalence of SARS-CoV-2 IgG antibodies in children and corresponding parents, in order to improve surveillance and estimate the prevalence of asymptomatic or subclinical COVID-19 cases. A prospective multicenter study was conducted between March and June 2021 in Greece. Children admitted to the hospital or examined in outpatient clinics for reasons other than COVID-19 and their parents were tested for anti-Spike SARS-CoV-2 IgG in serum. A questionnaire about clinical and demographic data was completed. The study included 823 participants: 427 children and 396 corresponding parents. The overall seroprevalence was 16.4% in parents and 13.8% in children. Among families with ≥ 1 seropositive child or parent, the combination of a seropositive parent and a corresponding seronegative child was 29.6%, a seronegative parent and a corresponding seropositive child was 24.7%, and a seropositive child with a corresponding seropositive parent was 45.7%. Age, level of education, and school or work attendance were not significantly associated with increased seropositivity. On the contrary, ethnic minority of Roma, close contact with known COVID-19 case, previous symptoms consistent with COVID-19, and mass gatherings were risk factors for seropositivity. The spread of SARS-CoV-2 during a period of lockdown in Greece was low in children and comparable to adults most likely due to intrafamilial transmission. Accordingly, it is unlikely that children have boosted virus transmission. • In the earliest months of the pandemic, it was demonstrated that children had significantly lower seroprevalence rates than the older age groups, due to the fact that children had decreased exposure to the virus, because of early public health interventions, such as school and day care closure. • Later, further studies reported that children have similar incidence rate of SARS-CoV-2 infection compared to adults in households and community settings. • In this seroprevalence study, the spread of SARS-CoV-2 infection during a period of lockdown in Greece with the predominance of the Alpha-variant was particularly low in children and comparable to adults, most likely due to intrafamilial transmission. • These study findings will be useful for decisions regarding non-pharmaceutical interventions during the pandemic, and especially, to guide in designing and implementing appropriate containment measures for schools and social gatherings.

Identifiants

pubmed: 36383284
doi: 10.1007/s00431-022-04681-8
pii: 10.1007/s00431-022-04681-8
pmc: PMC9666986
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-449

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Lipsitch M, Swerdlow DL, Finelli L (2020) Defining the epidemiology of Covid-19 – studies needed. N Engl J Med 382:1194–1196
doi: 10.1056/NEJMp2002125
WHO Coronavirus Disease (COVID-19) Dashboard (2020). https://covid19.who.int/ . Accessed 20 Sept 2020
Greek Ministry of Education and Religious Affairs (2020) Temporary ban on the operation of all educational structures. Athens. Greek. Available from: https://www.minedu.gov.gr/news/44308-10-03-20-prosorini-apagorefsi-tis-ekpaideftikis-leitourgias-olon-tonekpaideftikon-domon . Accessed 26 Sept 2022
European Union Agency for Fundamental Rights (FRA) (2020) Coronavirus COVID-19 outbreak in the EU Fundamental Rights Implications. Vienna: FRA. Available from: https://fra.europa.eu/sites/default/files/fra_uploads/greece-report-covid-19-april-2020_en.pdf . Accessed 26 Sept 2022
Bryant JE, Azman AS, Ferrari MJ et al (2020) Serology for SARS-CoV-2: apprehensions, opportunities, and the path forward. Sci Immunol 5:eabc6347
Valdivia A, Torres I, Huntley D, Alcaraz MJ, Albert E, Solano de la Asunción C, González C, Ferrer J, Navarro D (2020) Caveats in interpreting SARS-CoV-2 IgM(+)/IgG(-) antibody profile in asymptomatic health care workers. J Med Virol. https://doi.org/10.1002/jmv.26400
doi: 10.1002/jmv.26400
Peeling RW, Olliaro PL (2020) The time to do serosurveys for COVID-19 is now. Lancet Respir Med 8:836–838
doi: 10.1016/S2213-2600(20)30313-1
Byambasuren O, Cardona M, Bell K, Clark J, McLaws M.L, Glasziou P (2020) Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv
Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, Zhou L, Liu J (2020) Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis 20:410–411
doi: 10.1016/S1473-3099(20)30114-6
Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J et al (2020) Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16–23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study. J Infect 80:e1–e13
doi: 10.1016/j.jinf.2020.03.006
He X, Lau, EH, Wu P et al (2020) Temporal dynamics in viral shedding and transmissibility of COVID-19. medRxiv
Verity R, Okell LC, Dorigatti I et al (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 20:669–677
doi: 10.1016/S1473-3099(20)30243-7
Lipsitch M, Swerdlow DL, Finelli L (2020) Defining the epidemiology of Covid-19 - studies needed. N Engl J Med 382:1194–1196
doi: 10.1056/NEJMp2002125
WHO (2020) Population-based age-stratified seroepidemiological investigation protocol for COVID-19 virus infection. https://apps.who.int/iris/handle/10665/331656 . Accessed 26 Sept 2022
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H et al (2020) Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet 396(10247):313–319
doi: 10.1016/S0140-6736(20)31304-0
Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404–413
doi: 10.1093/biomet/26.4.404
Chung E, Chow EJ, Wilcox NC, Burstein R, Brandstetter E, Han PD et al (2021) Comparison of symptoms and RNA levels in children and adults with SARS-CoV-2 infection in the community setting. JAMA Pediatr 175(10):e212025
doi: 10.1001/jamapediatrics.2021.2025
Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA et al (2022) Incidence rates, household infection risk, and clinical characteristics of SARS-CoV-2 infection among children and adults in Utah and New York City. New York JAMA Pediatr 176(1):59–67
doi: 10.1001/jamapediatrics.2021.4217
The Centers for Disease Control and Prevention (CDC) (2022). Symptoms of COVID-19. Available in: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html . Accessed 26 Sept 2022
The Centers for Disease Control and Prevention (CDC) (2022). Contact tracing. Available in: https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/appendix.html . Accessed 26 Sept 2022
McLean HQ, Grijalva CG, Hanson KE, Zhu YG, Deyoe JE, Meece JK et al (2022) Household transmission and clinical features of SARS-CoV-2 infections by age in 2 US Communities. Pediatrics
Tönshoff B, Müller B, Elling R, Renk H, Meissner P, Hengel H et al (2021) Prevalence of SARS-CoV-2 infection in children and their parents in Southwest Germany. JAMA Pediatr 175:586–593
doi: 10.1001/jamapediatrics.2021.0001
Dethioux L, Dauby N, Montesinos I, Rebuffat E, Hainaut M (2022) SARS-CoV-2 seroprevalence in children and their family members, July-October 2020, Brussels. Eur J Pediatr 181:1009–1016
doi: 10.1007/s00431-021-04284-9
Lee B, Raszka WV (2020) COVID-19 transmission and children: the child is not to blame. Pediatrics e2020004879
Merckx J, A. Labrecque J, S. Kaufman J (2020) Transmission of SARS-CoV-2 by children. Dtsch Arztebl Int 117:553–560
Li F, Li Y-Y, Liu M-J et al (2021) Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis 21:617–628
doi: 10.1016/S1473-3099(20)30981-6
Sun K, Wang W, Gao L et al (2021) Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science 371:eabe2424
Laws RL, Chancey RJ, Rabold EM et al (2021) Symptoms and transmission of SARS-CoV-2 among children - Utah and Wisconsin, March-May 2020. Pediatrics 147
Viner RM, Mytton OT, Bonell C et al (2021) Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis. JAMA Pediatr 175:143–156
doi: 10.1001/jamapediatrics.2020.4573
Silverberg SL, Zhang BY, Li SNJ, Burgert C, Shulha HP, Kitchin V et al (2022) Child transmission of SARS-CoV-2: a systematic review and meta-analysis. BMC Pediatr 22:172
doi: 10.1186/s12887-022-03175-8
Cook B, Wayne GF, Valentine A, Lessios A, Yeh E (2013) Revisiting the evidence on health and health care disparities among the Roma: a systematic review 2003–2012. Int J Public Health 58:885–911
doi: 10.1007/s00038-013-0518-6
Dostal M, Topinka J, Sram RJ (2010) Comparison of the health of Roma and non-Roma children living in the district of Teplice. Int J Public Health 55:435–441
doi: 10.1007/s00038-010-0133-8
Kaditis AG, Gourgoulianis K, Tsoutsou P, Papaioannou AI, Fotiadou A, Christina M et al (2008) Spirometric values in Gypsy (Roma) children. Respir Med 102:1321–1328
doi: 10.1016/j.rmed.2008.03.025
Monasta L, Andersson N, Ledogar RJ, Cockcroft A (2008) Minority health and small numbers epidemiology: a case study of living conditions and the health of children in 5 foreign Romá camps in Italy. Am J Public Health 98:2035–2041
doi: 10.2105/AJPH.2007.129734
Emeruwa UN, Ona S, Shaman JL, Turitz A, Wright JD, Gyamfi-Bannerman C, Melamed A (2020) Associations between built environment, neighborhood socioeconomic status, and SARS-CoV-2 infection among pregnant women in New York City. JAMA 324:390–392
doi: 10.1001/jama.2020.11370
Kannan S, Shaik Syed Ali P, Sheeza A (2021) Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci 25:8019–8022

Auteurs

Dimitra Dimopoulou (D)

Second Department of Pediatrics, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Second Department of Paediatrics, Thivon and Leivadias Str, 11526, Athens, Greece. dimi_med@hotmail.com.

Maria Kyritsi (M)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Katerina Dadouli (K)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Eleni Vergadi (E)

School of Medicine, Department of Paediatrics, University of Crete, University General Hospital of Heraklion, Heraklion, Greece.

Ekaterini Tsiligianni (E)

Department of Microbiology, "P. & A. Kyriakou" Children's Hospital, Athens, Greece.

Eleni Papadimitriou (E)

School of Health Sciences, Faculty of Medicine, Department of Paediatrics, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.

Artemis Mavridi (A)

Third Department of Paediatrics, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Spyridon Giannakopoulos (S)

Department of Pediatrics, University Hospital of Ioannina, Ioannina, Greece.

Georgia Tsiourvopoulou (G)

Department of Pediatrics, University Hospital of Ioannina, Ioannina, Greece.

Maria Palyvou (M)

Medical School, Department of Paediatrics, University of Patras, Patras, Greece.

Evangelia Angeli (E)

Medical School, Department of Paediatrics, University of Patras, Patras, Greece.

Nikitas Brikos (N)

First Department of Paediatrics, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Irini Eleftheriou (I)

Second Department of Pediatrics, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Second Department of Paediatrics, Thivon and Leivadias Str, 11526, Athens, Greece.

Vassiliki Spoulou (V)

First Department of Paediatrics, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Athanasios Michos (A)

First Department of Paediatrics, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Despoina Gkentzi (D)

Medical School, Department of Paediatrics, University of Patras, Patras, Greece.

Ekaterini Siomou (E)

Department of Pediatrics, University Hospital of Ioannina, Ioannina, Greece.

Vassiliki Papaevangelou (V)

Third Department of Paediatrics, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Ioanna Grivea (I)

School of Health Sciences, Faculty of Medicine, Department of Paediatrics, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.

George Syrogiannopoulos (G)

School of Health Sciences, Faculty of Medicine, Department of Paediatrics, University General Hospital of Larissa, University of Thessaly, Larissa, Greece.

Emmanouil Galanakis (E)

School of Medicine, Department of Paediatrics, University of Crete, University General Hospital of Heraklion, Heraklion, Greece.

Christos Hadjichristodoulou (C)

Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Maria Tsolia (M)

Second Department of Pediatrics, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Second Department of Paediatrics, Thivon and Leivadias Str, 11526, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH